https://www.astrazeneca.com/content/dam/az/PDF/ Pharmaceuticals in the environment continued Assess the environmental risk of our medicines to support drug marketing authorisations Make our ERA data and safe discharge standard concentrations visible on our web pages Set safe discharge standards and actively manage the environmental risks associated with the APIs discharged from our manufacturing operations and supply chain Conduct ecopharmacovigilance (EPV) to review emerging science, looking for new information that might change the way we assess the environmental risks associated with our APIs Revise our safe discharge limits and ERAs if reliable data justifies	a	change	in	our	 environmental protection goals.